Mechanistic target of rapamycin (mTOR) is a protein kinase that regulates a range of processes important in cancer, such as cell proliferation and autophagy, and many inhibitors of mTOR have been developed for cancer treatment [107]. The gene discussed is WEE1; the disease is cancer.